News|Articles|July 11, 2025

The Future of Drug Pricing: Most Favored Nation, PBMs, and Patient Access

During the Reshaping Rx: Navigating 2025 Drug Pricing Policies webinar, panelists discussed the Most Favored Nation executive order, bills aimed at pharmacy benefit managers (PBMs), and other drug pricing policies.

During a conversation on the Trump administration’s 2025 drug pricing policies, panelists discussed the implications of the Most Favored Nation (MFN) order, the broader context of drug pricing reforms, and efforts to address pharmacy benefit manager (PBM) reform through greater transparency. Watch the full discussion.